These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 32552933)

  • 1. [Effect of Bmi-1 on Multidrug Resistance in K562/ADR Cells and Its Mechanisms].
    Zhao BX; Liu SQ; Dong SC; Jing RN; Meng XX
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Jun; 28(3):758-766. PubMed ID: 32552933
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of phosphatase and tensin homology deleted on chromosome 10 (PTEN) gene transfection on reversal of multidrug resistance in K562/ADM cells.
    Cheng Z; Yang N; Liang W; Yan X; Li L; Pan L
    Leuk Lymphoma; 2012 Jul; 53(7):1383-9. PubMed ID: 22185283
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reversal effect of PI3-K inhibitor LY294002 on P-glycoprotein-mediated multidrug resistance of human leukemia cell line K562/DNR and gastric cancer cell line SGC7901/ADR.
    Zhang Y; Qu XJ; Liu YP; Yang XH; Hou KZ; Teng YE; Zhang JD
    Ai Zheng; 2009 Feb; 28(2):97-9. PubMed ID: 19550116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The multidrug resistance can be reversed for the decrease of P-gp and LRP by inhibiting PI3K/Akt/NF-κB signal pathway in nasopharynx carcinoma.
    Liu J; Zhu M; Feng Y; Tang Q; Xu M
    Biosci Rep; 2020 May; 40(5):. PubMed ID: 32400857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Reversal effect of nuclear factor-κB protease inhibitor PDTC on multidrug resistance of K562/AO₂ cells and its mechanism].
    Yang TT; Xue TY; Xu W
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Aug; 18(4):903-8. PubMed ID: 20723297
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dioscin restores the activity of the anticancer agent adriamycin in multidrug-resistant human leukemia K562/adriamycin cells by down-regulating MDR1 via a mechanism involving NF-κB signaling inhibition.
    Wang L; Meng Q; Wang C; Liu Q; Peng J; Huo X; Sun H; Ma X; Liu K
    J Nat Prod; 2013 May; 76(5):909-14. PubMed ID: 23621869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Molecular mechanism of reversing multi-drug resistance of K562/AO2 by puerarin].
    Chen JW; Tao S; Luo R; Zhang GS; Xu YX
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2008 Mar; 33(3):216-21. PubMed ID: 18382055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting P-Glycoprotein: Nelfinavir Reverses Adriamycin Resistance in K562/ADR Cells.
    Liu W; Meng Q; Sun Y; Wang C; Huo X; Liu Z; Sun P; Sun H; Ma X; Liu K
    Cell Physiol Biochem; 2018; 51(4):1616-1631. PubMed ID: 30497065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Reversion Mechanism Study of PESV to Multidrug Resistance at Leukemia Stem Cell Level].
    Yang XD; Shi ZX; Yan LX; Liu BS; Chen HY; Yan TG; Zhang WF; Yang X; Qin HR; Liu C; Ji HX
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2016 Jul; 36(7):867-874. PubMed ID: 30634217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Timosaponin A-III reverses multi-drug resistance in human chronic myelogenous leukemia K562/ADM cells via downregulation of MDR1 and MRP1 expression by inhibiting PI3K/Akt signaling pathway.
    Chen JR; Jia XH; Wang H; Yi YJ; Wang JY; Li YJ
    Int J Oncol; 2016 May; 48(5):2063-70. PubMed ID: 26984633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Silencing of the CrkL gene reverses the doxorubicin resistance of K562/ADR cells through regulating PI3K/Akt/MRP1 signaling.
    Yu J; Chen WX; Xie WJ; Chen RW; Lin DQ; You WW; Ye WL; Zhang HQ; Lin DH; Xu JP
    J Clin Lab Anal; 2021 Aug; 35(8):e23817. PubMed ID: 34114685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of Bmi-1 Silencing on the Proliferation of K562/ADM Cells in vitro and in vivo].
    Liu B; Liu YJ; Liu DD; Zhao BX; Zhang K; Jing RN; Dong SC; Meng XX
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Apr; 28(2):446-452. PubMed ID: 32319377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Reversal effect of berbamine on multidrug resistance of K562/A02 cells and its mechanism].
    Han YQ; Yuan JY; Shi YJ; Zhu Y; Wu SL
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2003 Dec; 11(6):604-8. PubMed ID: 14706144
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [NF-kappaB regulating expression of mdr1 gene and P-gp to reverse drug-resistance in leukemic cells].
    Wang Y; Liu X; Zhang HT; Yu M; Wang H
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Oct; 15(5):950-4. PubMed ID: 17956668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-103 confers the resistance to long-treatment of adriamycin to human leukemia cells by regulation of COP1.
    Wan L; Tian Y; Zhang R; Peng Z; Sun J; Zhang W
    J Cell Biochem; 2018 May; 119(5):3843-3852. PubMed ID: 29058777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tuberostemonine reverses multidrug resistance in chronic myelogenous leukemia cells K562/ADR.
    Wang YJ; Zhao HD; Zhu CF; Li J; Xie HJ; Chen YX
    J Cancer; 2017; 8(6):1103-1112. PubMed ID: 28529625
    [No Abstract]   [Full Text] [Related]  

  • 17. The Hsp90 inhibitor SNX-2112, induces apoptosis in multidrug resistant K562/ADR cells through suppression of Akt/NF-κB and disruption of mitochondria-dependent pathways.
    Wang R; Shao F; Liu Z; Zhang J; Wang S; Liu J; Liu H; Chen H; Liu K; Xia M; Wang Y
    Chem Biol Interact; 2013 Sep; 205(1):1-10. PubMed ID: 23777986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Reversal effect of peptide-modified chitosan tetramethylpyrazine nanoparticles on multidrug resistance in tumor cells].
    Xiang-Yang L; Qing F; Chen-Yang Z; Ming-Kun S; Hui MA; Li-Chun C; Ren Bao Li Gao A; Zhen-Long YU
    Zhongguo Zhong Yao Za Zhi; 2020 Nov; 45(22):5487-5494. PubMed ID: 33350210
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [NF-κ B mediates the effect of glucosylceramide synthase on P-glycoprotein modulation in a drug-resistance leukemia cell line].
    Zhang X; Xie K; Zou J; Li Y; Mu H; Zhang B; Xie P
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2014 Feb; 31(1):34-8. PubMed ID: 24510559
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Bmi-1-siRNA Regulates the Proliferation of K562 Leukemia Cells in vitro and in vivo by PTEN/pAKT Pathway].
    Liu YJ; Zhang K; Liu B; Liu DD; Zhao BX; Fu XL; Gou R; Meng XX
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2019 Jun; 27(3):685-691. PubMed ID: 31204917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.